Medical Communications

The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new …

Bristol-Myers Squibb has announced its financial results for the second quarter of 2016, noting sizeable year-on-year sales growth and leaps …

Fosun Pharmaceutical has agreed a deal to purchase an 86.1% stake of Gland Pharma, which will see the Chinese firm …

Pfizer has announced positive top-line results from oral clinical trials for tofacitinib in ulcerative colitis (Octave) sustain, the third Phase …

Sanofi has published its earnings results for Q2, which show a fall in sales and profits as their diabetes division …

Roche has warned that cancer patients in England are facing into an “uncertain future” as the new Cancer Drugs Fund …

Ashfield is understandably well placed to offer a balanced viewpoint on field sales teams. With over 20 years of experience, …

Biomarin has presented interim results from a Phase I/II study that is being hailed as positive “proof-of-concept” data for their …

Eli Lilly has announced that CEO John Lechleiter is set to retire, with David Ricks to assume the role as …

Ian Campbell has been named by Innovate UK as its first director for Health and Life Sciences. Innovate UK is …

Bristol-Myers Squibb has announced the appointment of Fouad Namouni to the position of oncology development head, effective July 25, 2016. …

Valeant Pharmaceuticals has announced that it has received a complete response letter from the FDA rejecting their new drug application …

MSD, known as Merck in the US and Canada, has received a setback in its bid to get new C. …

Pfizer and Spark Therapeutics have announced that the US Food and Drug Administration (FDA) has granted a breakthrough therapy designation …

Amgen and Allergan have announced the results from a Phase III study investigating ABP 980, their biosimilar candidate for Roche’s …